These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11280725)
1. Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers. Jiang GL; Huang S Cancer Res; 2001 Mar; 61(5):1796-8. PubMed ID: 11280725 [TBL] [Abstract][Full Text] [Related]
2. RIZ, the retinoblastoma protein interacting zinc finger gene, is mutated in genetically unstable cancers of the pancreas, stomach, and colorectum. Sakurada K; Furukawa T; Kato Y; Kayama T; Huang S; Horii A Genes Chromosomes Cancer; 2001 Feb; 30(2):207-11. PubMed ID: 11135439 [TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911 [TBL] [Abstract][Full Text] [Related]
4. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells. Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054 [TBL] [Abstract][Full Text] [Related]
6. Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability. Piao Z; Fang W; Malkhosyan S; Kim H; Horii A; Perucho M; Huang S Cancer Res; 2000 Sep; 60(17):4701-4. PubMed ID: 10987271 [TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers. Marot D; Opolon P; Brailly-Tabard S; Elie N; Randrianarison V; Connault E; Foray N; Feunteun J; Perricaudet M Gene Ther; 2006 Feb; 13(3):235-44. PubMed ID: 16208422 [TBL] [Abstract][Full Text] [Related]
8. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. He L; Yu JX; Liu L; Buyse IM; Wang MS; Yang QC; Nakagawara A; Brodeur GM; Shi YE; Huang S Cancer Res; 1998 Oct; 58(19):4238-44. PubMed ID: 9766644 [TBL] [Abstract][Full Text] [Related]
9. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo. Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255 [TBL] [Abstract][Full Text] [Related]
10. Combination gene therapy with p53 and Thoc1/p84 is more effective than either single agent in an animal model of human pancreatic adenocarcinoma. Yin S; Goodrich DW Int J Oncol; 2006 Mar; 28(3):781-5. PubMed ID: 16465385 [TBL] [Abstract][Full Text] [Related]
12. Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5. Liu XY; Qiu SB; Zou WG; Pei ZF; Gu JF; Luo CX; Ruan HM; Chen Y; Qi YP; Qian C Mol Ther; 2005 Apr; 11(4):531-41. PubMed ID: 15771956 [TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589 [TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor gene RIZ in cancer gene therapy (review). Canote R; Du Y; Carling T; Tian F; Peng Z; Huang S Oncol Rep; 2002; 9(1):57-60. PubMed ID: 11748455 [TBL] [Abstract][Full Text] [Related]
15. Adenovirus-p53-mediated gene therapy of anaplastic large cell lymphoma with t(2;5) in a nude mouse model. Turturro F; Heineke HL; Drevyanko TF; Link CJ; Seth P Gene Ther; 2000 Jun; 7(11):930-3. PubMed ID: 10849552 [TBL] [Abstract][Full Text] [Related]
16. Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model. Zhu DE; Höti N; Song Z; Jin L; Wu Z; Wu Q; Wu M Cancer Gene Ther; 2006 Aug; 13(8):762-70. PubMed ID: 16543917 [TBL] [Abstract][Full Text] [Related]
17. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy. Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754 [TBL] [Abstract][Full Text] [Related]
18. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin. Dong YB; Yang HL; McMasters KM Cancer Gene Ther; 2003 Mar; 10(3):168-78. PubMed ID: 12637937 [TBL] [Abstract][Full Text] [Related]
19. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy. Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895 [TBL] [Abstract][Full Text] [Related]
20. Tumor-specific chemo-radio-gene therapy for colorectal cancer cells using adenovirus vector expressing the cytosine deaminase gene. Ueno M; Koyama F; Yamada Y; Fujimoto H; Takayama T; Kamada K; Naito A; Hirao S; Mukogawa T; Hamada H; Nakajima Y Anticancer Res; 2001; 21(4A):2601-8. PubMed ID: 11724328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]